These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 25838421)

  • 1. High-Density Lipoprotein (HDL) Phospholipid Content and Cholesterol Efflux Capacity Are Reduced in Patients With Very High HDL Cholesterol and Coronary Disease.
    Agarwala AP; Rodrigues A; Risman M; McCoy M; Trindade K; Qu L; Cuchel M; Billheimer J; Rader DJ
    Arterioscler Thromb Vasc Biol; 2015 Jun; 35(6):1515-9. PubMed ID: 25838421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance of the percentage of cholesterol efflux capacity and total cholesterol efflux capacity in patients with or without coronary artery disease.
    Norimatsu K; Kuwano T; Miura SI; Shimizu T; Shiga Y; Suematsu Y; Miyase Y; Adachi S; Nakamura A; Imaizumi S; Iwata A; Nishikawa H; Uehara Y; Saku K
    Heart Vessels; 2017 Jan; 32(1):30-38. PubMed ID: 27106918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-density lipoprotein mediated cellular cholesterol efflux in acute coronary syndromes.
    Hafiane A; Jabor B; Ruel I; Ling J; Genest J
    Am J Cardiol; 2014 Jan; 113(2):249-55. PubMed ID: 24210679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for coronary artery disease in patients with elevated high-density lipoprotein cholesterol.
    DeFaria Yeh D; Freeman MW; Meigs JB; Grant RW
    Am J Cardiol; 2007 Jan; 99(1):1-4. PubMed ID: 17196452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-density lipoprotein cholesterol efflux capacity as a relevant predictor of atherosclerotic coronary disease.
    Ishikawa T; Ayaori M; Uto-Kondo H; Nakajima T; Mutoh M; Ikewaki K
    Atherosclerosis; 2015 Sep; 242(1):318-22. PubMed ID: 26246268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-Density Lipoprotein Particle Concentration and Size Predict Incident Coronary Artery Disease Events in a Cohort With Type 1 Diabetes.
    Costacou T; Vaisar T; Miller RG; Davidson WS; Heinecke JW; Orchard TJ; Bornfeldt KE
    J Am Heart Assoc; 2024 Jul; 13(14):e034763. PubMed ID: 38958152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-density lipoprotein cholesterol in coronary artery disease patients: is it as low as expected?
    Uzunlulu M; Oğuz A; Tigen K
    Anadolu Kardiyol Derg; 2005 Dec; 5(4):268-70. PubMed ID: 16330390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations in lipid transfers to HDL associated with the presence of coronary artery disease in patients with type 2 diabetes mellitus.
    Sprandel MC; Hueb WA; Segre A; Ramires JA; Kalil-Filho R; Maranhão RC
    Cardiovasc Diabetol; 2015 Aug; 14():107. PubMed ID: 26268997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantity and function of high density lipoprotein as an indicator of coronary atherosclerosis.
    Saku K; Zhang B; Ohta T; Arakawa K
    J Am Coll Cardiol; 1999 Feb; 33(2):436-43. PubMed ID: 9973024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of links between high-density lipoprotein genetics, functionality, and aortic valve stenosis risk in humans.
    Arsenault BJ; Dubé MP; Brodeur MR; de Oliveira Moraes AB; Lavoie V; Kernaleguen AE; Guauque-Olarte S; Mathieu P; Pibarot P; Messika-Zeitoun D; Bossé Y; Rhainds D; Rhéaume E; Tardif JC
    Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):457-62. PubMed ID: 24334872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired HDL2-mediated cholesterol efflux is associated with metabolic syndrome in families with early onset coronary heart disease and low HDL-cholesterol level.
    Paavola T; Kuusisto S; Jauhiainen M; Kakko S; Kangas-Kontio T; Metso J; Soininen P; Ala-Korpela M; Bloigu R; Hannuksela ML; Savolainen MJ; Salonurmi T
    PLoS One; 2017; 12(2):e0171993. PubMed ID: 28207870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association of non-HDL cholesterol with the presence of metabolic syndrome in North Indian subjects with and without CAD.
    Garg PR; Kabita S; Sinha E; Kalla L; Kaur L; Saraswathy KN
    Ann Hum Biol; 2013 Jan; 40(1):111-5. PubMed ID: 23198906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ApoCIII enrichment in HDL impairs HDL-mediated cholesterol efflux capacity.
    Luo M; Liu A; Wang S; Wang T; Hu D; Wu S; Peng D
    Sci Rep; 2017 May; 7(1):2312. PubMed ID: 28539597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low levels of high-density lipoprotein cholesterol predict the presence of coronary artery disease in patients with aortic aneurysms.
    Saigusa T; Izawa A; Miura T; Ebisawa S; Shiba Y; Miyashita Y; Tomita T; Koyama J; Fukui D; Takano T; Amano J; Ikeda U
    Angiology; 2014 Sep; 65(8):710-5. PubMed ID: 24019083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-density lipoproteins and coronary artery disease: a single-center cohort study.
    Schaffer A; Verdoia M; Barbieri L; Aprami TM; Suryapranata H; Marino P; Luca GD;
    Angiology; 2014 Sep; 65(8):696-702. PubMed ID: 24052525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diminished cholesterol efflux mediated by HDL and coronary artery disease in young male anabolic androgenic steroid users.
    Souza FR; Dos Santos MR; Porello RA; Fonseca GWPD; Sayegh ALC; Lima TP; Ferreira FD; Oliveira TF; Yonamine M; Takayama L; Pereira RMR; Negrão CE; Passarelli M; Rochitte CE; Alves MJNN
    Atherosclerosis; 2019 Apr; 283():100-105. PubMed ID: 30826541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sphingosine 1-phosphate levels in plasma and HDL are altered in coronary artery disease.
    Sattler KJ; Elbasan S; Keul P; Elter-Schulz M; Bode C; Gräler MH; Bröcker-Preuss M; Budde T; Erbel R; Heusch G; Levkau B
    Basic Res Cardiol; 2010 Nov; 105(6):821-32. PubMed ID: 20652276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing HDL Metabolism in Subjects with Elevated Levels of HDL Cholesterol and Coronary Artery Disease.
    Hancock-Cerutti W; Millar JS; Valentini S; Liu J; Billheimer JT; Rader DJ; Cuchel M
    Molecules; 2021 Nov; 26(22):. PubMed ID: 34833954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paradoxical coronary artery disease in humans with hyperalphalipoproteinemia is associated with distinct differences in the high-density lipoprotein phosphosphingolipidome.
    Hancock-Cerutti W; Lhomme M; Dauteuille C; Lecocq S; Chapman MJ; Rader DJ; Kontush A; Cuchel M
    J Clin Lipidol; 2017; 11(5):1192-1200.e3. PubMed ID: 28826666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased phospholipid transfer protein activity associated with the impaired cellular cholesterol efflux in type 2 diabetic subjects with coronary artery disease.
    Attia N; Nakbi A; Smaoui M; Chaaba R; Moulin P; Hammami S; Hamda KB; Chanussot F; Hammami M
    Tohoku J Exp Med; 2007 Oct; 213(2):129-37. PubMed ID: 17917406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.